| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/11/2006 | CN1278724C Externally used Chinese traditional medicine ointment |
| 10/11/2006 | CN1278691C Potent immunostimulants from microalgae |
| 10/11/2006 | CN1278679C Application of coniferyl ferulate in preparing anticancer medicine |
| 10/11/2006 | CN1278676C Curcumin injection and method for preparing the same |
| 10/10/2006 | US7119229 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions |
| 10/10/2006 | US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 10/10/2006 | US7119201 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 10/10/2006 | US7119124 Pharmaceutical compositions containing plasma protein |
| 10/10/2006 | US7119116 Direct aminolysis of a carbamate ester or hydrolysis to an acid followed by coupling with an amine; analgesics, disorders of eating, nervous system, psychology, sleep, urogenital, respiratory and gastrointestinal systems; antiischemic, anticarcinogenic, antiinflammatory agents, antiallergens |
| 10/10/2006 | US7119115 For therapy of treating tumors or cancerous cells |
| 10/10/2006 | US7119111 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
| 10/10/2006 | US7119104 Alpha-(oxy-, sulfo- or amino-)[3-(imidazolyl, oxazolyl or thiazolyl)alkylene(indazolyl, benzisoxazolyl or benzisothiazolyl)]acetic acids, esters or alkali salts |
| 10/10/2006 | US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases |
| 10/10/2006 | US7119096 Anticancer agents |
| 10/10/2006 | US7119090 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases, enzyme inhibitors |
| 10/10/2006 | US7119089 Phenothiazine kinesin inhibitors |
| 10/10/2006 | US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis |
| 10/10/2006 | US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 10/10/2006 | US7119081 Also estrogen phosphonates, thiophosphonates, sulphonates, sulphonamides, and N-acylsulfamates |
| 10/10/2006 | US7119080 Boronic ester and acid compounds, synthesis and uses |
| 10/10/2006 | US7119074 Treatment of cancers, tumors and malignancies using amphiphilic prodrugs |
| 10/10/2006 | US7118905 Nucleic acid encoding angiogenesis inhibitor |
| 10/10/2006 | US7118903 Comprises genetically engineered protein for use in treatment and prevention of cancer, obesity, cardiac, vascular, neurologic and or aging disorders |
| 10/10/2006 | US7118890 Antibodies to vertebrate delta proteins and fragments |
| 10/10/2006 | US7118856 Enzyme catalyst; polypeptides; crystal structure |
| 10/10/2006 | US7118767 Pharmaceutical composition for increasing the production of nitric oxide and IFN-γ, and process for preparation thereof |
| 10/10/2006 | US7118750 Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA |
| 10/10/2006 | US7118744 Immunogenic compositions for induction of anti-tumor immunity |
| 10/10/2006 | US7118740 Method for limiting the growth of cancer cells using an attenuated measles virus |
| 10/10/2006 | US7118731 Antitumor agents; anticancer agents; viricides; nucleoside derivative |
| 10/10/2006 | CA2352554C Substituted benzimidazoles and their use as parp inhibitors |
| 10/10/2006 | CA2350734C 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 10/10/2006 | CA2338415C Preparation of thioarabinofuranosyl compounds and use thereof |
| 10/10/2006 | CA2268968C Iminochlorin aspartic acid derivatives |
| 10/10/2006 | CA2268799C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same |
| 10/10/2006 | CA2262778C Conformationally constrained backbone cyclized somatostatin analogs |
| 10/10/2006 | CA2225366C Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
| 10/10/2006 | CA2219678C Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection or associated diseases |
| 10/10/2006 | CA2196640C Substituted quinazoline derivatives |
| 10/10/2006 | CA2158862C Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 10/10/2006 | CA2157905C Process for purifying taxoids |
| 10/05/2006 | WO2006105511A1 Monitoring and modulating hgf/hgfr activity |
| 10/05/2006 | WO2006105507A2 Indoloquinone tumor radiation sensitization |
| 10/05/2006 | WO2006105399A1 Methods for administering ixabepilone |
| 10/05/2006 | WO2006105386A1 Cdk2 inhibitors |
| 10/05/2006 | WO2006105313A2 Compositions of and methods of using oversulfated glycosaminoglycans |
| 10/05/2006 | WO2006105262A1 HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl |
| 10/05/2006 | WO2006105063A1 Heterobicylic inhibitors of tgfbeta |
| 10/05/2006 | WO2006104971A1 Atp competitive kinase inhibitors |
| 10/05/2006 | WO2006104461A1 Naphthalamide derivatives having antiproliferative activity |
| 10/05/2006 | WO2006104424A1 Method for obtaining protein growth factors, a growth factor and fibroblast proliferation inhibitor |
| 10/05/2006 | WO2006104406A1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments |
| 10/05/2006 | WO2006104289A1 Pharmaceutical composition for inhibition of tumor growth |
| 10/05/2006 | WO2006104280A1 Prophylactic/therapeutic agent for diabetes |
| 10/05/2006 | WO2006104199A1 Liposome composition for induction of immunity |
| 10/05/2006 | WO2006104161A1 THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING c-Met AUTOPHOSPHORYLATION INHIBITING POTENCY |
| 10/05/2006 | WO2006104099A1 RORα PROMOTING THE INDUCTION OF Bmal1 EXPRESSION |
| 10/05/2006 | WO2006103568A2 NEW CLASS OF Ϝδ T CELLS ACTIVATORS AND USE THEREOF |
| 10/05/2006 | WO2006103494A2 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 10/05/2006 | WO2006103255A1 Imidazopyridine derivatives useful as inos inhibitors |
| 10/05/2006 | WO2006103187A2 Method for administration of capecitabine |
| 10/05/2006 | WO2006102854A1 A conjugate of biomacromolecule with bioreductive and preparative method thereof |
| 10/05/2006 | WO2006102800A1 Nano-micellar preparation of anthracycline antitumor antibiotics wrapped by the polyethylene glycols derivative of phosphatide |
| 10/05/2006 | WO2006102789A1 Ferula fukanensis extract, the preperation method and the use in producing medicine thereof |
| 10/05/2006 | WO2006102717A1 Modulating angiogenesis with nod factors such as glucosamine oligosaccharides |
| 10/05/2006 | WO2006102716A1 A method of diagnosis and treatment and agents useful for same |
| 10/05/2006 | WO2006102715A1 Methods and agents for modulating cellular activity |
| 10/05/2006 | WO2006091972A3 Dimeric iap inhibitors |
| 10/05/2006 | WO2006077387A3 Novel benzamide derivatives |
| 10/05/2006 | WO2006068826A3 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors |
| 10/05/2006 | WO2006060809A3 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 10/05/2006 | WO2006058012A3 Gonadotropin releasing hormone receptor antagonists |
| 10/05/2006 | WO2006057884A3 2α-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND THEIR USES |
| 10/05/2006 | WO2006048248A3 Novel anthranilamide pyridinureas as vegf receptor kinase imhibitors |
| 10/05/2006 | WO2006015124A3 Fused ring heterocycle kinase modulators |
| 10/05/2006 | WO2006002889A3 Improved adjuvant therapy of g250-expressing tumors |
| 10/05/2006 | WO2005092392A3 Conjugated psychotropic drugs and uses thereof |
| 10/05/2006 | WO2005042028A3 Il-13 conjugated to an immunogen and uses thereof |
| 10/05/2006 | WO2004044163A3 Methods for identifying risk of melanoma and treatments thereof |
| 10/05/2006 | WO2003087306A8 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 10/05/2006 | US20060223990 Synthesis, deprotection, analysis & purification of RNA & ribozymes |
| 10/05/2006 | US20060223881 Use of gamma- tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 10/05/2006 | US20060223871 Thiophene-and thiazolesulfonamides as antineoplastic agents |
| 10/05/2006 | US20060223867 administering two or more timed doses of 7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[1-methyl-2-(2-methylsulfanyl-thiazol-4-yl)-vinyl]-4,17-dioxa-bicyclo[14.1.0]heptadecane-5,9-dione also called epothilone b; treating a drug resistant tumor; ovarian cancer |
| 10/05/2006 | US20060223853 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 10/05/2006 | US20060223844 Mitotic kinesin inhibitors |
| 10/05/2006 | US20060223839 5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5H-chromeno-[3,4-f]-quinolines as selective progesterone receptor modulator compounds |
| 10/05/2006 | US20060223836 New phenylalanine derivatives |
| 10/05/2006 | US20060223823 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 10/05/2006 | US20060223822 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 10/05/2006 | US20060223818 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-ylmethyl-benzamide methanesulfonate; antiproliferative agent |
| 10/05/2006 | US20060223815 Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use |
| 10/05/2006 | US20060223800 Pyrazolopyridines and pyrazolopyridazines adn antidiabetics |
| 10/05/2006 | US20060223784 Method and compositions for temporarily incapacitating subjects |
| 10/05/2006 | US20060223779 Method of screening for inhibitors of human Fatty Acid-CoA Ligase 4 |
| 10/05/2006 | US20060223768 Regulation of gene expression |
| 10/05/2006 | US20060223758 Treating treating angiogenic disease by administering therapeutically effective amount of compounds of the invention, for example, {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester; stability |
| 10/05/2006 | US20060223757 Applications in gene therapy, transgenic organisms, functional genomics, and other areas of cell and molecular biology. |
| 10/05/2006 | US20060223754 Human TSLP polynucleotides |
| 10/05/2006 | US20060223747 Therapeutic agent for soft tissue sarcoma |